(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 20.63%-890.54K | -15.32%-271.61K | 55.33%-722.92K | 141.49%173.56K | -318.08%-538.95K | -43.64%-1.12M | 18.73%-235.54K | 61.26%-1.62M | -103.84%-418.35K | 69.07%-128.91K |
Net income from continuing operations | -10.71%-469.63K | 35.54%-305.73K | 33.31%-1.83M | 60.15%-438.74K | 23.08%-492.11K | 27.81%-424.19K | -14.38%-474.29K | 89.68%-2.74M | 76.30%-1.1M | 10.06%-639.75K |
Operating gains losses | ---- | ---- | ---- | ---- | 87.27%39.05K | ---- | ---- | 240.48%39.53K | --0 | -80.31%20.85K |
Depreciation and amortization | -0.57%94.63K | 11.76%117.62K | -18.00%440.87K | -6.78%112.06K | -17.20%128.39K | -36.40%95.18K | -6.66%105.25K | 1.22%537.67K | -59.36%120.21K | 94.66%155.05K |
Asset impairment expenditure | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -96.74%495.46K | ---- | ---- |
Unrealized gains and losses of investment securities | --0 | ---7.08K | ---- | ---- | ---- | ---7.45K | --0 | ---- | ---- | ---- |
Remuneration paid in stock | 13.06%63.28K | --19.28K | 995.34%55.97K | --0 | --0 | --55.97K | --0 | -99.92%5.11K | --0 | -72.52%2.99K |
Other non cashItems | 17.26%86.69K | 44.18%83.41K | 337.59%459.55K | 196.26%236.21K | 548.53%91.56K | 316.70%73.93K | 979.83%57.85K | -15.92%105.02K | 100.70%79.73K | 23.64%14.12K |
Change In working capital | 27.30%-665.51K | -336.74%-179.11K | 358.49%150.02K | 2,410.53%295.63K | -196.22%-305.83K | -138.56%-915.45K | 265.93%75.66K | 30.49%-58.04K | 72.48%-12.8K | 266.61%317.83K |
-Change in receivables | 76.85%-51.18K | -155.93%-105.16K | 42.98%-106.24K | ---- | ---- | 38.88%-221.06K | 584.31%188.01K | -1,213.60%-186.32K | ---- | ---- |
-Change in inventory | -196.15%-15.16K | -67.66%8.84K | 171.29%53.5K | ---- | ---- | 65.58%-5.12K | 436.80%27.34K | -112.66%-75.05K | ---- | ---- |
-Change in prepaid assets | 108.69%4.29K | 85.05%-11.06K | -776.82%-25.32K | ---- | ---- | -515.67%-49.39K | -743.88%-74K | -99.15%3.74K | ---- | ---- |
-Change in payables and accrued expense | -83.36%32.08K | 90.47%-5.74K | 71.36%347.99K | ---- | ---- | 1,199.72%192.84K | -371.03%-60.18K | 146.02%203.08K | ---- | ---- |
-Change in other current liabilities | 52.18%-401.39K | -1,097.19%-66K | -40.69%-4.91K | ---- | ---- | -2,374.86%-839.4K | -116.25%-5.51K | 80.58%-3.49K | ---- | ---- |
-Change in other working capital | -3,606.72%-234.14K | ---- | ---115K | --30.62K | -196.22%-305.83K | --6.68K | ---- | ---- | ---- | 1,317.64%317.83K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 20.63%-890.54K | -15.32%-271.61K | 55.33%-722.92K | 141.49%173.56K | -318.08%-538.95K | -43.64%-1.12M | 18.73%-235.54K | 61.26%-1.62M | 3.81%-418.35K | 69.07%-128.91K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 136.14%390.25K | 717.83%172.8K | -1,030.17%-350.68K | -117.07%-126.81K | -232.75%-69.72K | -2,429.25%-1.08M | -1,512.58%-27.97K | 95.33%-31.03K | -131.50%-58.42K | -183.93%-20.95K |
Net PPE purchase and sale | 97.33%-28.86K | 85.02%-4.18K | -250.76%-353.2K | -168.98%-129.82K | -232.75%-69.72K | -3,126.60%-1.08M | -1,508.79%-27.89K | -2,140.16%-100.7K | -9,572.55%-48.27K | ---20.95K |
Net intangibles purchas and sale | -102.61%-853 | --0 | 123.33%2.52K | 127.92%3.02K | --0 | ---421 | ---75 | ---10.8K | ---10.8K | --0 |
Net business purchase and sale | --0 | --170.82K | --0 | --0 | --0 | --0 | --0 | 124.09%80.47K | -99.77%650 | --0 |
Net investment purchase and sale | --419.96K | --6.16K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 136.14%390.25K | 717.83%172.8K | -1,030.17%-350.68K | -117.07%-126.81K | -232.75%-69.72K | -2,429.25%-1.08M | -1,512.58%-27.97K | 95.33%-31.03K | -131.50%-58.42K | -183.93%-20.95K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 30.20%2.45M | 8.08%1.01M | -31.64%1.24M | -158.98%-188.04K | -24.27%565.52K | 61.95%1.88M | 4,726.28%936.55K | 10.60%1.82M | -2,218.94%-72.61K | 1,378.03%746.78K |
Net issuance payments of debt | -95.32%88.02K | -6.02%880.19K | -30.40%1.24M | -76.05%-190.04K | -24.27%565.52K | 11,810.74%1.88M | 4,726.28%936.55K | 1,660.37%1.78M | -222.77%-107.95K | 2,332.92%746.78K |
Proceeds from stock option exercised by employees | --360.16K | --132K | -94.34%2K | ---- | ---- | --0 | --0 | -96.04%35.34K | ---- | ---- |
Net other financing activities | --2M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 30.20%2.45M | 8.08%1.01M | -31.64%1.24M | -158.98%-188.04K | -24.27%565.52K | 61.95%1.88M | 4,726.28%936.55K | 10.60%1.82M | -2,218.94%-72.61K | 1,378.03%746.78K |
Net cash flow | ||||||||||
Beginning cash position | 22.95%2.18M | 15.16%1.27M | 17.71%1.1M | -14.59%1.41M | 37.85%1.45M | 182.61%1.77M | 17.71%1.1M | -77.37%936.17K | 38.91%1.65M | -35.67%1.05M |
Current changes in cash | 705.83%1.95M | 35.71%913.38K | 0.78%167.09K | 74.28%-141.28K | -107.23%-43.15K | -175.41%-321.52K | 318.45%673.04K | 105.18%165.79K | -117.49%-549.38K | 232.59%596.92K |
End cash Position | 184.17%4.13M | 22.95%2.18M | 15.16%1.27M | 15.16%1.27M | -14.59%1.41M | 37.85%1.45M | 182.61%1.77M | 17.71%1.1M | 17.71%1.1M | 38.91%1.65M |
Free cash from | 58.21%-920.25K | -4.66%-275.79K | 38.00%-1.08M | 109.27%44.24K | -306.15%-608.67K | -170.32%-2.2M | 10.33%-263.51K | 58.49%-1.74M | -9.64%-477.42K | 64.04%-149.86K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.